Item 5. Other Information
Item 5. Other Information.
On September 12, 2011, we filed with the Securities and Exchange Commission a Current Report on Form 8-K in which we disclosed our sale of our Indian subsidiary, our agreements with Futenco, the resignation of certain of our Directors and other matters. We refer readers to such from 8-K for further information on such disclosed matters.
Item 6. Exhibits.
The following exhibits are being filed as part of this Quarterly Report on Form 10-Q.
Exhibit
Number
Exhibit Description
10.1
Agreement executed by Clenergen India Private Limited on May 17, 2011 and Vastani Company SA
10.1
Agreement, executed by Clenergen Corporation on September 5, 2011 and by Futenco [Incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the Securities and Exchange Commission on September 12, 2011.]
10.2
Transfer Agreement, effective as of September 5, 2011, between Clenergen Corporation and Maxrise Powergen Limited. [Incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]
10.3
Shareholders Agreement, effective as of September 5, 2011, between Clenergen Corporation and Futenco. [Incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]
10.4
Shareholders Agreement, effective as of September 5, 2011, between Clenergen Corporation and Futenco. [Incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]
10.5
Shareholders Agreement, effective as of August 31, 2011, between Clenergen Corporation and Futenco. [Incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]
10.6
License Agreement, effective as of September 1, 2011, between Clenergen Corporation and Futenco. [Incorporated by reference to Exhibit 10.6 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]
31.1
Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.
31.2
Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer.
32.1
Section 1350 Certification of Principal Executive Officer.
32.2
Section 1350 Certification of Principal Financial Officer.
99.1
Resignation letter dated September 5, 2011, of Alex Worrall. [Incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]
99.2
Resignation letter dated September 5, 2011, of Sanil Kumar. [Incorporated by reference to Exhibit 99.2 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]
99.3
Resignation letter dated September 5, 2011, of Pamela Peeters. [Incorporated by reference to Exhibit 99.3 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]
99.4
Resignation letter dated September 5, 2011, of David Sonnenberg. [Incorporated by reference to Exhibit 99.4 to the Current Report on Form 8-K (Date of Report: September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]
99.5
18
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated September 19, 2011
Clenergen Corporation
By:
/s/ Mark L.M. Quinn
Mark L.M. Quinn
Executive Chairman and Chief Executive Officer of the Board
(Duly Authorized Officer
and Principal Executive Officer)
By:
/s/ Mike Starkie
Mike Starkie
Acting Chief Financial Officer
(Principal Financial and Accounting Officer)
19
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.